TerrAscend Corp. (TSX: TSND)
Health Care · Pharmaceuticals · CA
CA$0.73
-3.33% today · -37.0% 1Y
TerrAscend Corp. (TSX: TSND) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $157.10M and employs 933 people.
Over the last twelve months the share price has lost 37.0%, trading between 0.53 and 2.00.
Tweenvest scores TerrAscend Corp. across four factors: quality 48/100, value 77/100, growth 76/100. Its strongest factor is value.
TSND price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $157.10M
- Revenue (TTM)
- $263.91M
- P/E
- —
- EPS
- -0.13
- Dividend yield
- —
- Beta (5Y)
- 2.17
- 52-week high
- CA$2.00
- 52-week low
- CA$0.53
- Avg volume (3M)
- —
- Shares outstanding
- 309.18M
- Employees
- 933
- Next earnings
- —
About TerrAscend Corp.
TerrAscend Corp. operates as a comprehensive cannabis enterprise, engaging in the cultivation, processing, and distribution of cannabis products for both medical and regulated adult recreational markets across Canada and the United States. In addition to its core cannabis operations, the firm also develops and supplies hemp-derived wellness items to retail outlets and crafts specialty cannabis-infused edibles. It further expands its market presence by managing a network of retail dispensaries under The Apothecarium brand name in California, Pennsylvania, and New Jersey. The company's portfolio encompasses various integrated businesses and brands, including Gage Growth, Pinnacle, Ilera Healthcare, Valhalla Confections, State Flower, and Arise Bioscience Inc., among others. Established in 2017, TerrAscend maintains its corporate headquarters in Mississauga, Canada.
- ISIN
- CA88105E1088
- Founded
- 2017
- Listed since
- May 3, 2017
- Exchange
- The Toronto Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| MediWound Ltd.NasdaqGM: MDWD | $161.89M | $12.53 | -0.08% |
| Accent Microcell LimitedNSEI: ACCENTMIC | $161.05M | Rs649.75 | -3.01% |
| Hyundai Pharmaceutical Co., Ltd.KOSE: A004310 | $159.76M | ₩7,760.00 | -6.95% |
| Zhaoke Ophthalmology LimitedSEHK: 6622 | $158.23M | HK$2.27 | -8.65% |
| AGP LimitedKASE: AGP | $156.49M | PKRs155.48 | +2.42% |
| Cenra Inc.TWSE: 3716 | $155.60M | NT$34.15 | +0.74% |
| Societe de Promotion Pharmaceutique du Maghreb S.A.CBSE: PRO | $155.42M | MAD— | — |
| Anlon Healthcare LimitedNSEI: AHCL | $154.38M | Rs28.11 | -14.46% |
Figures last refreshed Oct 11, 2026.